• NVO

Barclays says buy Novo Nordisk stock 'into this critically important catalyst'

• AMGN
• LLY
• NVO

Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares

• LLY
• NVO
• REGN

China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug

• LLY
• MERC
• NVO

Weight-loss drug coverage rises among largest US employers, Mercer survey finds

• JNJ
• MIWO00000PUS
• NVO
• SWAV
• UK100

Healthcare executives expect more IPOs and corporate dealmaking in 2025

Healthcare executives see increased IPOs and M&A activity in 2025, citing geopolitical risks as major concerns, with confidence improving in the sector's outlook.

• LLY
• NVO

Exclusive-Medicaid fuels US coverage of Novo, Lilly weight-loss drugs

U.S. government health plans dominate weight-loss drug coverage, with significant access through Medicaid, while private insurers lag, impacting healthcare costs and availability.

• BAVA
• CAG
• CCEP
• CHD
• CL
• GIS
• KDP
• KHC
• LLY
• MNST
• MRNA
• NVAX
• NVO
• PEP
• PFE
• PG
• RHHBY
• SNY

Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job

U.S. drugmaker shares fell after Trump appointed Robert F. Kennedy Jr. to lead health, raising investor concerns over vaccine policies and agency oversight.

• AMZN
• HIMS
• NVO

Amazon's push into telehealth knocks shares of Hims & Hers

• CTLT
• LLY
• NVO

EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal

EU regulators are reviewing Novo Holdings' $16.5 billion acquisition of Catalent, seeking feedback on market competition concerns and vertical links in contract manufacturing sectors.

• AUTL
• COIN
• CSCO
• NVO
• SPNS
• TSLA

Tesla, Coinbase and Trump Media rise premarket; Sapiens slumps

US stock futures rose, driven by key movers like Tesla and Coinbase. Notably, Sapiens fell sharply after cutting revenue guidance. Several stocks benefited from analyst upgrades and regulatory approvals.